Sponsorship verdict
Sponsorship possible
One solid signal, not two. Worth applying, and worth asking about sponsorship early.
-
✓
Employer is on a government sponsor recordThe US Department of Labor certified 2 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Feb 2026) — the step every H-1B hire needs first.
-
?
The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
-
?
No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
-
✓
Confirmed live todayWhen a source last listed this job as open.
Details and sources
- Employer is on a government sponsor record
- The US Department of Labor certified 2 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Feb 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
- No salary bar for this route
- H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.
About the role
For more than 25 years, Corcept has been singularly focused on the science of cortisol, a powerful hormone that when unregulated, can play a role in a broad range of diseases.
Our commercial portfolio includes treatments for hypercortisolism and oncology, and the company has discovered more than 1,000 proprietary selective cortisol modulators and glucocorticoid receptor antagonists. With advanced clinical trials in patients with hypercortisolism, solid tumors, ALS and liver disease, Corcept is unlocking the power of cortisol modulation to help address some of the most devastating diseases patients face today.
Corcept is headquartered in Redwood City, California. To learn more, visit www.corcept.com .
The Oncology MSL role is an exciting opportunity to work at a well-established pharmaceutical company with a first in class oncology product in a platform extending across multiple therapeutic areas. This role is a chance to join a high performing team that is well-respected in the cross-functional Oncology Business Unit. This will cover the Northwest Territory and include territories in the following states: Washington, Oregon, Idaho, Montana, Wyoming, Alaska and Utah.
The MSL team focuses on thought leader engagement, insight gathering, and scientific education and will represent Corcept to the highest ethical and professional standards and in accordance with guidelines, directions, and policies. The MSL will ascribe to the mission, vision, and values of the Medical Affairs Team and the overall Oncology Business Unit.
Responsibilities:
• Model and promote Corcept’s key principles: collaborating effectively, embracing possibilities, following the data, and leading by doing, to build a culture of accountability, innovation, and trust
• Engage in clinically meaningful scientific discussions with thought leaders and other healthcare providers (HCPs) in gynecological oncology and other malignancies to enhance their knowledge of Corcept and the role of glucocorticoid receptor antagonism in oncology
• Proactively or responsively, when appropriate requests are made, support Corcept products via health care professional communication and education through in-depth scientific presentations and education
• Respond to medical inquiries from HCPs in a timely and scientifically accurate manner
• Engage in scientific exchange on Corcept’s non-clinical and clinical trial data as well as the clinical development Consistently ask thoughtful questions or challenge internal/external stakeholders
• Develop and maintain strong working relationships with thought leaders, patient advocacy organizations, and oncology associations (like GOG and ASCO as well as regional organizations) within the oncology community
• Capture, analyze, and communicate insights and intelligence from the medical and scientific community in a compliant manner to help inform decisions by Corcept. Communications will clearly and effectively frame insights in a usable manner
• Support company-sponsored clinical trials, investigator-initiated studies (IIS), scientific communications, publications, clinical and scientific education, advisory boards, and congresses
• Maintain the highest standards of scientific, clinical, and technical expertise in relevant therapeutic area(s)
• Able to critically review scientific literature and provide evidence-based insights
• Demonstrate teamwork and collaboration within Medical Affairs (MA) as well as cross-functionally with Clinical Development, Clinical Operations, Market Access, Marketing, Commercial, Data Analytics, etc. Exchange ideas and knowledge compliantly among Oncology functions. Establish regular channels with colleagues across functions for sharing and synthesizing information
• Attend and participate in medical confer
Apply on company site ↗